Brief: Cabaletta Bio Reports Q4, Full Year 2021 Financial Results
17/03/2022 11:09
March 17 (Reuters) - Cabaletta Bio Inc CABA.O :
* CABALETTA BIO REPORTS FOURTH QUARTER AND FULL YEAR 2021
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
* CABALETTA BIO INC - ENDED 2021 WITH $122.2 MILLION IN CASH
ON
HAND TO FUND OPERATIONS THROUGH 3Q 2023
* CABALETTA BIO INC QTRLY NET LOSS PER VOTING AND NON-VOTING
SHARE, BASIC AND DILUTED $0.49
Source text for Eikon: ID:nGNX1DPlJy
Further company coverage: CABA.O
Recent news on Cabaletta Bio
See all newsCabaletta Bio Q1 net loss widens as R&D costs rise
Brief: First Patients Dosed With Cabaletta Bio’S Rese-Cel Manufactured On Cellares' Automated Cell Shuttle™ Platform
Brief: IND Amendment Clearance Obtained For Clinical Manufacturing Of Rese-Cel From Cabaletta Bio Using Cellares' Automated Platforms
Cabaletta Bio reports smaller-than-expected Q3 loss
U.S. RESEARCH ROUNDUP-Beacon Financial, Comerica, Doximity